A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/14/2006	US7135197 Mixtures of group V compounds such as bismuth subsalicylate, water and antideposit agents having storage stability, used for prohylaxis of nausea, dyspepsia or diarrhea
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	US7135194 Subunguicide, and method for treating onychomycosis
11/14/2006	US7135192 Lipid, Dna complex with detectable labels
11/14/2006	US7135191 Suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals
11/14/2006	US7135190 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents
11/14/2006	US7135189 Compositions and techniques for localized therapy
11/14/2006	US7135188 Methods and compositions for immunotherapy of cancer
11/14/2006	US7135183 Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
11/14/2006	US7135180 Non- boiling foam generation and penetration of preservative agents at temperatures near the phase transfer temperature of the lipid membranes, to preserve bioactive material in a dried foam matrix
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	US7135164 Andrographis paniculata gel as an adjunct in the treatment of periodontitis
11/14/2006	CA2417887C Particulate composition of eletriptan
11/14/2006	CA2294783C Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
11/14/2006	CA2261787C Multi-layered osmotic device
11/14/2006	CA2232435C Preservative systems for pharmaceutical compositions containing cyclodextrins
11/13/2006	CA2790058A1 Herceptin® adjuvant therapy
11/09/2006	WO2006119498A2 Pharmaceutical compositions with synchronized solubilizer release
11/09/2006	WO2006119291A2 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	WO2006119286A1 Edible film for transmucosal delivery of nutritional supplements
11/09/2006	WO2006119049A2 Methods for prolonging feline life
11/09/2006	WO2006119009A1 Non-lithotripsic kidney-stone therapy
11/09/2006	WO2006118547A1 Hyperbranched polymers and their applications
11/09/2006	WO2006118460A1 Hydrogen bonded hydrogels
11/09/2006	WO2006118331A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
11/09/2006	WO2006118329A1 Stable emulsion composition
11/09/2006	WO2006118278A1 Temperature-sensitive liposome and temperature-sensitive drug release system
11/09/2006	WO2006118265A1 Composition containing antidementia agent
11/09/2006	WO2006118260A1 Electrostatic bonding type polymer vesicle
11/09/2006	WO2006118246A1 Transdermal absorption accelerator
11/09/2006	WO2006118210A1 Method of preventing dihydropyridine compound from degradation
11/09/2006	WO2006118173A1 Trenadermal absorption preparation
11/09/2006	WO2006118137A1 Granular preparation containing biguanide compound
11/09/2006	WO2006118074A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same
11/09/2006	WO2006118017A1 Stabilized composition
11/09/2006	WO2006117881A1 Active foam
11/09/2006	WO2006117567A2 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
11/09/2006	WO2006117405A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
11/09/2006	WO2006116948A1 Interleukin-6 polyethylene glycol conjugate and its preparing method and use
11/09/2006	WO2006101815A3 Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems
11/09/2006	WO2006098754A3 A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability
11/09/2006	WO2006097558A3 Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules
11/09/2006	WO2006096491A9 Anti-ctla-4 antibody compositions
11/09/2006	WO2006084141A8 Suspension formulation of interferon
11/09/2006	WO2006083799A3 Suspending vehicles comprising a hydrophilic solvent, a hydrophobic solvent, a polymer and the suitable pump-driven dosage form
11/09/2006	WO2006051241A3 Method for coupling non-immunogenic molecules, intermediate compound, final product obtained and uses thereof
11/09/2006	WO2006019327B1 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction
11/09/2006	WO2005117985A3 Lipopolyplex construct with an integrin binding peptide for delivery of nucleic acids, peptides or drugs
11/09/2006	WO2005097087A3 Merged ion channel modulating compounds and uses thereof
11/09/2006	WO2005089429A3 Sfec, a sperm flagellar energy carrier protein
11/09/2006	WO2005070026A3 Drug immunoconjugate combination therapy
11/09/2006	WO2005053749A3 Thiol-cleavable linkage between polymer and ligand
11/09/2006	WO2005049091A3 Antibody-targeted nanoparticulate active agent delivery
11/09/2006	US20060253934 Methods for conditional transgene expression and trait removal in plants
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252700 Immunomodulator
11/09/2006	US20060252690 Factor VII or VIIa - Like Molecules
11/09/2006	US20060252689 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252682 Liquid growth hormone formulation and process of preparation thereof
11/09/2006	US20060252130 Method for linking molecular substances
11/09/2006	US20060252127 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252124 Methods and compositions for generating human monoclonal antibodies
11/09/2006	US20060251719 Sustained-release hydrogel preparation
11/09/2006	US20060251716 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251707 Uv stable transdermal therapeutic plaster
11/09/2006	US20060251703 Composition comprising an edible acid or its acidic salt and the use thereof
11/09/2006	US20060251675 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
11/09/2006	US20060251668 Tumor-specific recognition molecules
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251640 administering a D-amino acid oxidase which is chemically conjugated with a polymer, for accumulation in the tumor tissue, then administering D-amino acid which is a substrate for the D-amino acid oxidase, which releases reactive oxygen species; improved tumor selective cytotoxic activity results
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251580 Lectin conjugates
11/09/2006	US20060251579 Medicament for the two-step perioperative therapy of solid tumours
11/09/2006	DE102005019628A1 Formulierung zur dermalen Anwendung Formulation for dermal application
11/09/2006	CA2836827A1 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
11/09/2006	CA2608283A1 Pharmaceutical compositions with synchronized solubilizer release
11/09/2006	CA2607777A1 Transdermal absorption enhancer
11/09/2006	CA2607419A1 Granular preparation containing biguanide compound
11/09/2006	CA2607020A1 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
11/09/2006	CA2606989A1 Vascular targeting of ocular neovascularization
11/09/2006	CA2606858A1 Permeable capsules
11/09/2006	CA2606724A1 Edible film for transmucosal delivery of nutritional supplements
11/09/2006	CA2606714A1 Non-lithotripsic kidney-stone therapy
11/09/2006	CA2606506A1 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	CA2606151A1 Composition for sleep inducer comprising essential oil as active ingredient, percutaneous sleep inducer comprising thereof, and method for producing thereof
11/09/2006	CA2605773A1 Stable emulsion composition
11/09/2006	CA2604617A1 Composition containing anti-dementia drug
11/09/2006	CA2603020A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
11/09/2006	CA2536857A1 Biodegradable chitosan-peg compositions, and methods of use
11/08/2006	EP1719528A2 Compositions and methods for treatment of angiogenesis in pathological lesions
11/08/2006	EP1719527A1 Antitumor agent
11/08/2006	EP1719523A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
11/08/2006	EP1719505A2 Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
11/08/2006	EP1719502A1 Composition for easing human childbirth
11/08/2006	EP1718755A1 Method for the production of hyperbranched polysaccharide fractions
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718667A2 Heterocyclic self-immolative linkers and conjugates

1 ... 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 ... 1712